We are live on ! Find out more
ODT

Odonate Therapeutics, Inc. Common Stock
ODT

Delisted

ODT was delisted on the 14th of January, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of ODT yet.

ODT Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q2 2022, worth a combined $0 — down 100% from $7.13M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ODT and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Boxer Capital, exiting entirely with an estimated $5.55M sold.

  • 0 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q2 2022, down from 8 in Q1 2022.
  • Funds reported $0 of Odonate Therapeutics, Inc. Common Stock stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q2 2022 and 8 closed out, a net change of -8 holders.
  • The largest Odonate Therapeutics, Inc. Common Stock seller in Q2 2022 was Boxer Capital, an estimated $5.55M sold.

Based on aggregated 13F filings for Q2 2022.